4//SEC Filing
Corcoran Gavin 4
Accession 0001209191-18-043532
CIK 0001636050other
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 6:23 PM ET
Size
8.7 KB
Accession
0001209191-18-043532
Insider Transaction Report
Form 4
Corcoran Gavin
EVP of R&D
Transactions
- Award
Employee Stock Option (Right to Buy)
2018-07-16+250,000→ 250,000 totalExercise: $2.46Exp: 2028-07-16→ Common Shares (250,000 underlying) - Award
Employee Stock Option (Right to Buy)
2018-07-16+200,000→ 200,000 totalExercise: $2.46Exp: 2028-07-16→ Common Shares (200,000 underlying)
Footnotes (3)
- [F1]The option vests over a period of four years, with one quarter of the common shares underlying the option vesting on July 16, 2019 and the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer on each such date.
- [F2]The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.
- [F3]One-third of the option will vest at such time as the Issuer's stock price is equal to $7.38; one-third of the option will vest at such time as the Issuer's stock price is equal to $12.30, and one-third of the option will vest at such time as the Issuer's stock price is equal to $17.22, in each case subject to the Reporting Person providing continuous service to the Issuer on each such date.
Documents
Issuer
Axovant Sciences Ltd.
CIK 0001636050
Entity typeother
Related Parties
1- filerCIK 0001745995
Filing Metadata
- Form type
- 4
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 6:23 PM ET
- Size
- 8.7 KB